Loading...
XNAS
QTRX
Market cap229mUSD
Jul 09, Last price  
5.90USD
1D
-9.79%
1Q
22.66%
IPO
-67.55%
Name

Quanterix Corp

Chart & Performance

D1W1MN
XNAS:QTRX chart
P/E
—
P/S
1.69
EPS
—
Div Yield, %
—
Shrs. gr., 5y
8.87%
Rev. gr., 5y
19.01%
Revenues
135m
+10.68%
12,180,00017,585,00022,874,00037,632,00056,734,00086,377,000110,556,000104,952,000122,368,000135,436,000
Net income
-39m
L+19.17%
-15,943,000-23,173,000-27,019,000-31,045,000-40,796,000-31,530,000-57,688,000-96,700,000-32,334,000-38,531,000
CFO
-35m
L+86.03%
-12,517,000-17,742,000-22,106,000-28,721,000-26,187,000-23,365,000-47,907,000-48,272,000-18,902,000-35,164,000
Earnings
Aug 06, 2025

Profile

Quanterix Corporation, a life sciences company, engages in development and marketing of digital immunoassay platforms that advances precision health for life sciences research and diagnostics in North America, Europe, the Middle East, Africa, and the Asia Pacific regions. It offers HD-X instrument, a sensitive automated multiplex protein detection platform; and SR-X instrument that enables researchers to apply Simoa detection technology in various applications, including direct detection of nucleic acids. The company also provides SP-X instrument that is based on Simoa planar array technology for the measurement of multiplex chemiluminescent immunoassays. The company's products include assay kits and other consumables such as reagents. In addition, it offers contract research services, including sample testing, homebrew assay development, and custom development services. The company primarily operates in the areas of neurology, oncology, cardiology, infectious diseases, and inflammation. It sells its products for the life science research sector primarily to laboratories associated with academic and governmental research institutions, as well as pharmaceutical, biotechnology, and contract research companies through a direct sales force, support organizations, and distributors or sales agents. The company was formerly known as Digital Genomics, Inc. and changed its name to Quanterix Corporation in August 2007. Quanterix Corporation was incorporated in 2007 and is headquartered in Billerica, Massachusetts.
URL
https://www.quanterix.com/
IPO date
Dec 07, 2017
Employees
3,200
Domiciled in
US
Incorporated in
US

Valuation

Title
USD in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2024‑122023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑122015‑12
Income
Revenues
135,436
10.68%
122,368
16.59%
104,952
-5.07%
Cost of revenue
190,037
166,820
177,879
Unusual Expense (Income)
NOPBT
(54,601)
(44,452)
(72,927)
NOPBT Margin
Operating Taxes
434
719
65
Tax Rate
NOPAT
(55,035)
(45,171)
(72,992)
Net income
(38,531)
19.17%
(32,334)
-66.56%
(96,700)
67.63%
Dividends
Dividend yield
Proceeds from repurchase of equity
3,066
2,691
2,311
BB yield
-0.75%
-0.26%
-0.45%
Debt
Debt current
4,756
8,482
2,687
Long-term debt
69,986
115,910
85,521
Deferred revenue
1,227
1,415
Other long-term liabilities
1,873
(36,046)
Net debt
(214,380)
(196,932)
(253,129)
Cash flow
Cash from operating activities
(35,164)
(18,902)
(48,272)
CAPEX
(3,368)
(3,788)
(11,726)
Cash from investing activities
(82,265)
(148,401)
(11,206)
Cash from financing activities
456
2,691
2,311
FCF
(62,683)
(53,474)
(82,377)
Balance
Cash
289,122
321,324
338,740
Long term investments
2,597
Excess cash
282,350
315,206
336,089
Stockholders' equity
(473,161)
(436,215)
(404,748)
Invested Capital
842,443
831,251
809,035
ROIC
ROCE
EV
Common stock shares outstanding
38,367
37,594
36,991
Price
10.63
-61.12%
27.34
97.40%
13.85
-67.33%
Market cap
407,841
-60.32%
1,027,820
100.62%
512,325
-66.43%
EV
193,461
830,888
259,196
EBITDA
(46,245)
(36,073)
(67,578)
EV/EBITDA
Interest
5,131
Interest/NOPBT